Totient, a Viva Biotech Portfolio Company, Achieves the Acquisition with AbSci
Anji Pharma Launches Phase 3 Trial for ANJ900
Viva Biotech Included in the MSCI China Small Index Constituent Stocks
Shanghai EPN and BioMap Reached a Strategic Cooperation
TechnoDerma Announced New Progress in Phase I Clinical Trials of TDM-105795 in the U.S.